Follow us on the latest updates on transactions, events, research and market insights from the life sciences industry
To receive our updates per e-mail, please sign-up here:
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 02/2023”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences ... Read more
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 01/2023”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences ... Read more
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 12/2022”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As ... Read more
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 12/2022”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences ... Read more
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 11/2022”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As ... Read more
The ever-increasing venture capital funding for European life sciences companies halted in 2022. With a roughly EUR 9.6bn volume, the overall financing for European life sciences companies in 2022 decreased significantly compared to 2021 (EUR ... Read more
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 11/2022”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences ... Read more
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 10/2022”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As ... Read more
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 10/2022”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences ... Read more
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 09/2022”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As ... Read more
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 09/2022”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences ... Read more
In 2022, the venture capital funding for life sciences in Europe continues to weaken, further widening the gap to 2021 (EUR 9.4bn vs. EUR 6.5bn). The cumulative financing volume in August 2022 falls by more ... Read more
